In summary, to the best of our knowledge, our study is the first to confirm that a Chk1 inhibitor combined with γ-irradiation suppresses the invasiveness of breast cancer cell lines, resulting from inhibiting the expression of S100A4. Here, S100A4 is linked to breast carcinoma.